glp-1 news today october 9 2025 Drugs Are Rewriting the Rules of Food The expanding landscape of GLP-1

PMID 16284435

Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells

The lack of pregnancy-related criteria for adequacy of B-vitamin status is in turn a major limitation in identifying pregnant women most at risk of B-vitamin deficiency

The SURPASS phase III clinical trials for tirzepatide involve more than 13,000 patients with T2D and aim to gain a better understanding of its efficacy and safety (ClinicalTrials.gov Identifier: NCT04255433)

Intramuscular injections (IM) directly deliver vitamins, minerals, and amino acids into the muscle, allowing for better absorption and faster results than oral supplements